Grapefruit plus psychiatric medications

The mechanism

Grapefruit juice contains furanocoumarins, particularly bergamottin and 6',7'-dihydroxybergamottin. These compounds irreversibly bind to and inactivate intestinal CYP3A4. Recovery requires new enzyme synthesis, which takes 24 to 72 hours.

Important nuance: grapefruit affects intestinal CYP3A4 much more than hepatic CYP3A4. Drugs metabolized primarily by intestinal first-pass CYP3A4 (with low oral bioavailability under normal conditions) show the biggest jump in exposure when grapefruit blocks that first-pass. Drugs with high oral bioavailability (little first-pass extraction) are much less affected.

Grapefruit also weakly inhibits P-glycoprotein, adding to bioavailability effects for some drugs.

Which psychiatric drugs are affected

High impact (avoid or use with caution):

• Buspirone (BuSpar): bioavailability can rise 9-fold with grapefruit. Effect is clinically significant.
• Lurasidone (Latuda): exposure rises 7-fold with grapefruit. FDA labeling explicitly prohibits grapefruit while on lurasidone.
• Ziprasidone (Geodon): affected, though less dramatically than lurasidone.

Moderate impact:

• Quetiapine (Seroquel): exposure rises modestly (roughly 20 to 80 percent). Clinical significance depends on dose and patient.
• Cariprazine (Vraylar): metabolized by CYP3A4, some effect expected.
• Aripiprazole (Abilify): partially metabolized by CYP3A4, but also CYP2D6, so effect is modest.
• Carbamazepine (Tegretol): moderate effect; carbamazepine is also a CYP3A4 substrate and inducer, complicating the picture.

Benzodiazepines with grapefruit effect:

• Midazolam (Versed): substantial. Not typically an outpatient issue since midazolam is mostly IV.
• Triazolam (Halcion): substantial effect.
• Alprazolam (Xanax): modest effect.
• Diazepam (Valium), clonazepam (Klonopin): minimal effect; primarily metabolized by other pathways.

Minimal to no effect:

• Sertraline (Zoloft), escitalopram (Lexapro), fluoxetine (Prozac), paroxetine (Paxil), citalopram (Celexa)
• Venlafaxine (Effexor), duloxetine (Cymbalta)
• Bupropion (Wellbutrin)
• Mirtazapine (Remeron)
• Vortioxetine (Trintellix)
• Lithium
• Valproate, lamotrigine
• Most stimulants (methylphenidate, amphetamines)

What "grapefruit" includes

• Fresh grapefruit
• Grapefruit juice (frozen concentrate, bottled, fresh-squeezed)
• Grapefruit soda (Fresca and similar)
• Seville oranges (used in marmalade)
• Pomelo
• Tangelos (partial effect)
• Sour orange in Latin American cooking

Not affected:

• Regular navel oranges, mandarins, tangerines
• Orange juice from regular oranges
• Lemons, limes
• Grapefruit-flavored artificial products with no actual grapefruit

How much grapefruit is a problem

Even small amounts can produce clinically meaningful effects. A single glass of grapefruit juice (8 oz / 240 mL) can inhibit intestinal CYP3A4 for 24 hours. Half a grapefruit produces similar effect.

Timing does not save you: taking grapefruit in the morning and medication in the evening does not prevent interaction because the CYP3A4 inactivation persists for 1 to 3 days regardless of timing.

Practical guidance

For lurasidone: FDA label explicitly prohibits grapefruit. Patients starting lurasidone should be counseled specifically.

For buspirone: strongly avoid grapefruit. Effects can include severe sedation, dizziness, and syncope.

For quetiapine and other moderately-affected drugs: standard clinical guidance is to avoid, especially at higher doses or in older adults.

For patients who consume grapefruit regularly and are starting a new drug: check whether the drug is affected. If yes, discuss whether to change the drug, change the food, or accept modified dosing.

Common questions

Can I have grapefruit occasionally on quetiapine? Small amounts occasionally are usually tolerated but not universally. Standard clinical guidance is to avoid regular consumption. If a patient really wants grapefruit, discuss with the prescriber and consider whether a lower quetiapine dose is appropriate.

Does grapefruit affect sertraline or escitalopram? Not clinically significantly. SSRIs are metabolized primarily by CYP2C19 (with some CYP2D6 and CYP3A4 contribution), and the CYP3A4 fraction is small enough that grapefruit does not produce meaningful effect.

What about orange juice? Regular oranges (navel, Valencia) do not contain furanocoumarins and do not affect CYP3A4. Regular orange juice is safe with essentially all psychiatric medications.

What about grapefruit juice in cocktails? The furanocoumarin effect is not destroyed by alcohol or mixing. A grapefruit martini or Paloma has the same interaction potential as pure grapefruit juice.

How long after eating grapefruit is it safe to take the medication? 72 hours is the safe window in most cases. Some sources use 24 hours, but the inhibition can persist for 3 days after a single serving.

Is Seville orange in marmalade actually a problem? Yes, in principle. Traditional Seville orange marmalade contains furanocoumarins similar to grapefruit. Occasional small servings are unlikely to be clinically meaningful, but daily marmalade with breakfast on lurasidone or buspirone could produce interaction.

Does pink grapefruit differ from white grapefruit? Both contain furanocoumarins. Color does not affect the interaction.

What about grapefruit essential oil or supplements? Concentrated grapefruit extracts can produce strong CYP3A4 inhibition. Avoid.

Sources

• Bailey DG, Dresser G, Arnold JM. Grapefruit-medication interactions: forbidden fruit or avoidable consequences? CMAJ. 2013;185(4):309-316.
• Bailey DG, Arnold JM, Spence JD. Grapefruit juice-drug interactions. Br J Clin Pharmacol. 1998;46(2):101-110.
• Lilja JJ, Kivistö KT, Backman JT, Neuvonen PJ. Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life. Eur J Clin Pharmacol. 2000;56(5):411-415.
• FDA prescribing information for lurasidone (Latuda), buspirone, quetiapine.
• Lilja JJ, Kivistö KT, Backman JT, Lamberg TS, Neuvonen PJ. Grapefruit juice substantially increases plasma concentrations of buspirone. Clin Pharmacol Ther. 1998;64(6):655-660.